CCM
ONC

Coldstream Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Coldstream Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-591
Closed -$201K – 1280
2025
Q3 		$201K Buy
+591
New +$179K ﹤0.01% 1152
2025
Q2 		– Sell
-63
Closed -$17.1K – 3512
2025
Q1 		$17.1K Buy
+63
New +$14.7K ﹤0.01% 2168

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Coldstream Capital Management's ONC Position: Q4 2025 in Review

Coldstream Capital Management sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 591 shares — an estimated $201K sold.

Coldstream Capital Management first reported a position in ONC in Q1 2025 and held it in 2 quarters. The position peaked at $201K in Q3 2025. 286 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • Coldstream Capital Management reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 591 BeOne Medicines Ltd shares in Q4 2025, an estimated $201K.
  • Coldstream Capital Management first reported a position in BeOne Medicines Ltd in Q1 2025 and held it in 2 quarters.
  • Coldstream Capital Management's BeOne Medicines Ltd position peaked at $201K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on Coldstream Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.